Evidence map›Paper›PMID 31886370›Full record

ArticleData in brief2020

Cultivated

Maria Siniagina, Maria Markelova, Alexander Laikov, Eugenia Boulygina, Dilyara Khusnutdinova, Anastasia Kharchenko, Albina Misbakhova, Tatiana Grigoryeva

Open access · goldAbstract read
In one paragraph

Article in Data in brief, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 12 citations in OpenAlex.

  1. Review
  2. Role of adherent invasiveWorld journal of clinical cases · 2022
    Review
  3. Diversity and Adaptations ofMicroorganisms · 2021
    Article
  4. United European gastroenterology journal · 2020
    Article
  5. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Maria SiniaginaKazan Federal University, Russian Federation.
Maria MarkelovaKazan Federal University, Russian Federation.
Alexander LaikovKazan Federal University, Russian Federation.
Eugenia BoulyginaKazan Federal University, Russian Federation.
Dilyara KhusnutdinovaKazan Federal University, Russian Federation.
Anastasia KharchenkoKazan Federal University, Russian Federation.
Albina MisbakhovaKazan Medical State University, Russian Federation.
Tatiana GrigoryevaKazan Federal University, Russian Federation.
Kazan Federal University · RUKazan State Medical University · RU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Dysbiosis of the gut microbiota in inflammatory bowel disease (IBD) patients is of great interest. It has been reported that Crohn's disease (CD) is associated with a general decrease in microbial diversity [1]. Altered microbial composition and function in CD results in imbalance in host-bacteria interaction and increased immune stimulation [2]. It is shown that microbiota in CD is characterized by increased proportion of

Indexed as

Crohn's diseaseEscherichia coliHuman gut microbiotaWhole-genome sequencing

Identifiers

PMID31886370
PMCPMC6923290
OpenAlexW2992941459

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.